APA (7th ed.) Citation

C, P., E, B., R, B., G, C., GM, G., Y, S., & R, G. (2020). COVID-19 as part of the hyperferritinemic syndromes: The role of iron depletion therapy. Immunologic research, 68(4), 213. https://doi.org/10.1007/s12026-020-09145-5

Chicago Style (17th ed.) Citation

C, Perricone, Bartoloni E, Bursi R, Cafaro G, Guidelli GM, Shoenfeld Y, and Gerli R. "COVID-19 as Part of the Hyperferritinemic Syndromes: The Role of Iron Depletion Therapy." Immunologic Research 68, no. 4 (2020): 213. https://doi.org/10.1007/s12026-020-09145-5.

MLA (9th ed.) Citation

C, Perricone, et al. "COVID-19 as Part of the Hyperferritinemic Syndromes: The Role of Iron Depletion Therapy." Immunologic Research, vol. 68, no. 4, 2020, p. 213, https://doi.org/10.1007/s12026-020-09145-5.